Integrated Diagnostics Holdings plc
IDGXF
$0.4591
-$0.009-1.92%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.88% | -6.64% | -5.03% | -3.87% | -4.36% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.88% | -6.64% | -5.03% | -3.87% | -4.36% |
| Cost of Revenue | -3.63% | -10.03% | -6.61% | -4.87% | -5.54% |
| Gross Profit | 8.30% | -0.92% | -2.34% | -2.14% | -2.36% |
| SG&A Expenses | -7.28% | -7.70% | -10.50% | -11.63% | -17.12% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -619.30% | -351.39% | -458.77% | -363.08% | -2,027.37% |
| Total Operating Expenses | -5.62% | -11.08% | -8.58% | -7.43% | -8.59% |
| Operating Income | 27.10% | 12.22% | 11.13% | 14.07% | 17.56% |
| Income Before Tax | 3.39% | -10.78% | 40.47% | 12.12% | 68.55% |
| Income Tax Expenses | 6.09% | -1.05% | 11.31% | 0.85% | 23.44% |
| Earnings from Continuing Operations | 2.06% | -15.47% | 57.11% | 18.18% | 105.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -100.77% | -45.90% | 15.14% | 115.51% | 11.01% |
| Net Income | -7.20% | -17.68% | 53.68% | 23.57% | 90.99% |
| EBIT | 27.10% | 12.22% | 11.13% | 14.07% | 17.56% |
| EBITDA | 15.94% | 3.85% | 3.35% | 5.55% | 7.83% |
| EPS Basic | -4.79% | -15.63% | 55.40% | 24.45% | 91.79% |
| Normalized Basic EPS | -3.71% | -10.28% | 40.94% | 20.51% | 18.93% |
| EPS Diluted | -4.79% | -15.63% | 55.40% | 24.45% | 91.79% |
| Normalized Diluted EPS | -3.71% | -10.28% | 40.94% | 20.51% | 18.93% |
| Average Basic Shares Outstanding | -2.62% | -1.84% | -1.06% | -0.53% | 0.00% |
| Average Diluted Shares Outstanding | -2.62% | -1.84% | -1.06% | -0.53% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |